retatrutide suppliers Company linked to raid on illicit weight-loss drug facility still selling unlicensed drugs | Consumer affairs Retatrutide and the Grey Market:

However, its cutting-edge triple-agonist design comes with a clear financial reality: it is currently the most expensive metabolic compound to synthesize and study

(Confirms UK marketing authorization for the tirzepatide precedent, September 2022.) [MHRA Products] National Institute for Health and Care Excellence (NICE)

It is available via private prescription in the UK but is not routinely commissioned on the NHS and is not NICE-recommended for routine NHS use

This distinction matters

That gap is large

Licensed options include semaglutide (Wegovy), tirzepatide (Mounjaro), liraglutide (Saxenda), and orlistat, all available through NHS or regulated private services